PRINCETON, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announced that two oral presentations and 20 posters across its development programs will be included at ...

NN, Inc.'s new CEO Harold Bevis, with significant turnaround experience, has initiated cost cuts. Click here to read why NNBR stock is a Strong Buy.

The way you see nutrition labels on food packaging is about to change. By 2025, new front-of-package labels will start ...

WARNING: SEVERE HYPERSENSITIVITY REACTIONS Hypersensitivity Reactions Including Anaphylaxis Patients treated with Lamzede have experienced hypersensitivity reactions, including anaphylaxis.

Henry Brown escapes slavery by mailing himself in a small wooden box to a free state. But that’s less than half his story. In ...

Kite, a Gilead Sciences company, will share four posters that add to the growing body of evidence to support the clinical use of its chimeric antigen receptor (CAR) T-cell therapy portfolio, at the ...

Although the president had been talking about the idea for weeks, there had been no meetings on the subject, and senior ...

Top Trump administration officials on Wednesday walked back elements of President Trump’s proposal to “take over” Gaza and ...